Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy ...
Background: This study was performed to assess the prevalence of dry eye syndrome and diabetic retinopathy (DR ... included 34 patients (17.1%) with mild non proliferative DR (NPDR), 34 patients ...
The following is a summary of “Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study,” published in the January 2025 issue of Ophthalmology by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback